CLINICAL RESEARCH: ACUTE MYOCARDIAL INFARCTION
Longer-Term Follow-Up of Patients Recruited to the REACT (Rescue Angioplasty Versus Conservative Treatment or Repeat Thrombolysis) Trial
Amanda Carver, MSc, BA (Hons), RN*,*,
Suzanne Rafelt, BSc (Hons), MSc ,
Anthony H. Gershlick, BSc, MB, BS ,
Kathryn L. Fairbrother, BA, RN ,
Sarah Hughes, BA (Hons), RN ,
Robert Wilcox, BSc, DM|| for the REACT Investigators
* Queensland Health, Brisbane, Queensland, Australia
Department of Cardiovascular Sciences, University of Leicester, Leicester, United Kingdom
Department of Academic Cardiology, University Hospitals of Leicester NHS Trust, Leicester, United Kingdom
Cardio-Respiratory Directorate, University Hospitals of Leicester NHS Trust, Leicester, United Kingdom
|| University Hospital, Nottingham, United Kingdom
Manuscript received September 10, 2008;
revised manuscript received March 23, 2009,
accepted March 24, 2009.
* Reprint requests and correspondence: Ms. Amanda Carver, Population Health, Office of the Chief Health Officer, Queensland Health, Citilink Business Centre, Campbell Street, Herston, Brisbane 4001, Queensland, Australia (Email: amanda.carver{at}bigpond.com).
Objectives: To evaluate the longer-term outcomes for rescue percutaneous coronary intervention (R-PCI).
Background: Thrombolysis remains an important, commonly used reperfusion therapy, yet failure to achieve complete reperfusion occurs relatively frequently. A number of recent trials have focused on the management of patients with thrombolytic failure, including the REACT (Rescue Angioplasty Versus Conservative Treatment or Repeat Thrombolysis) trial, which demonstrated a significant 6-month benefit favoring R-PCI. However, longer-term maintenance of benefit for R-PCI has not been demonstrated.
Methods: Rates of the primary composite end point (major adverse cardiac and cerebrovascular events) to 1 year and mortality to a median of 4.4 years in 427 patients included in the 3 randomized arms of the REACT trial (repeat lysis, conservative therapy, and R-PCI) were analyzed.
Results: One-year event-free survival for patients randomized to R-PCI was 81.5%, compared with 64.1% for repeat thrombolysis and 67.5% for conservative therapy (overall p = 0.004). Adjusted hazard ratio was 0.44 (95% confidence interval [CI]: 0.28 to 0.71; p = 0.0008) for R-PCI versus repeat thrombolysis and 0.51 (95% CI: 0.32 to 0.83; p = 0.007) for R-PCI versus conservative therapy. Adjusted hazard ratio for longer-term (median 4.4 years) overall mortality for R-PCI versus repeat thrombolysis was 0.41 (95% CI: 0.22 to 0.75; p = 0.004) and 0.43 (95% CI: 0.23 to 0.79; p = 0.006) for R-PCI versus conservative therapy. There was no difference in either analysis between repeat thrombolysis and conservative strategies.
Conclusions: Rescue PCI, previously shown to be superior in the short term to both repeat thrombolysis and conservative therapy, maintains benefit in terms of long-term mortality. This strategy for failed lysis should be mandated as part of thrombolytic-based ST-segment elevation myocardial infarction protocols.
Key Words: ST-segment elevation myocardial infarction failed thrombolysis rescue percutaneous coronary intervention
|
Abbreviations and Acronyms
| | AMI = acute myocardial infarction | | CABG = coronary artery bypass grafting | | CI = confidence interval | | CVA = cerebrovascular accident | | ECG = electrocardiograph | | HR = hazard ratio | | MACCE = major adverse cardiac and cerebrovascular events | | PCI = percutaneous coronary intervention | | P-PCI = primary percutaneous coronary intervention | | re-AMI = recurrent acute myocardial infarction | | R-PCI = rescue percutaneous coronary intervention | | STEMI = ST-segment elevation myocardial infarction | | TIMI = Thrombolysis In Myocardial Infarction |
|
Related Articles
-
The Only Better Alternative to Rescue Percutaneous Coronary Intervention Is Primary Percutaneous Coronary Intervention
- Gjin Ndrepepa, Albert Schömig, and Adnan Kastrati
J. Am. Coll. Cardiol. 2009 54: 127-129.
[Full Text]
[PDF]
-
Inside This Issue
J. Am. Coll. Cardiol. 2009 54: A24.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
S. R. Dixon, C. L. Grines, and W. W. O'Neill
The year in interventional cardiology.
J. Am. Coll. Cardiol.,
May 18, 2010;
55(20):
2272 - 2286.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. N. DeMaria, J. J. Bax, O. Ben-Yehuda, G. K. Feld, B. H. Greenberg, J. Hall, M. Hlatky, W. Y.W. Lew, J. A.C. Lima, A. S. Maisel, et al.
Highlights of the Year in JACC 2009
J. Am. Coll. Cardiol.,
January 26, 2010;
55(4):
380 - 407.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. W. Buckley and B. K. Nallamothu
Percutaneous Coronary Intervention After Successful Fibrinolytic Therapy for ST-Segment Elevation Myocardial Infarction: Better Late Than Never
J. Am. Coll. Cardiol.,
January 12, 2010;
55(2):
111 - 113.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Ndrepepa, A. Schomig, and A. Kastrati
The Only Better Alternative to Rescue Percutaneous Coronary Intervention Is Primary Percutaneous Coronary Intervention.
J. Am. Coll. Cardiol.,
July 7, 2009;
54(2):
127 - 129.
[Full Text]
[PDF]
|
 |
|
|